Paul Place

As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: discuss issues related to Pharmacy sector in Canada. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Fertilizers Act and Regulations - in respect of labelling requirements for bulk shipments. Clean Fuel Standard (CFS) This regulation is of significant impact to our business. We are concerned there will be insufficient implementation time; design must be flexible; federal/provincial harmonization. Climate change principles As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: • Canadian Co-operatives Act – in respect to review and changes to the Act, understanding by the federal government for specialized co-op development programs that will help start and grow new and existing co-ops with specific sectors or populations and a viable business model. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Transportation of Dangerous Goods Act – in respect to rail and truck transportation of products and appropriate classification and stewardship of products. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Safe Food for Canadians Act and Food & Drug Act & Regulations - in respect of managing risk to food safety and supporting a safe food system for Canada. Including food commodities (fruit & vegetables, grains & oilseeds), including their inspection, their safety, their labelling, and advertising, and their import. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Feeds Act – in respect to possible amendments and policy interpretations. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Federal Budget – in respect to providing resources for environmental initiatives, including climate change, renewables, fiscal policy, investing in water and wastewater infrastructure, pollution abatement and enforcement. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Clean Fuels Standards and Climate Change Principles. FCLs actions to reduce carbon footprint through waste diversion activities and the reduction of emissions, etc. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Chemical Management Plan – in respect to assessment of chemicals in commerce in the coatings industry and risk management initiatives to mitigate harm to human health and ecological systems. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Canada Customs Act & Regulations - in respect of establishing & implementing appropriate enforcement mechanisms and policies which affect the movement of products. As it pertains to the oil and gas industry, food/home and building supply/crop supplies/feed retailing, wholesaling and manufacturing industries: Agriculture Policy Framework/Growing Forward – in respect to supporting the development and implementation of a safe food supply chain for the Canadian marketplace and the ability to trace products for the food retailing industry along the supply chain.

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

Related to the life sciences, research and the digital ecosystems, we need to make sure that Canada creates an environment that is globally competitive Related to legislations on data privacy we need to make sure that Canada has legislations that are harmonized across provinces and federal governments as well as global standards. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines.

Research Canada is a collaborative advocacy leader working to achieve policy impact by strengthening political and public support for a robust health research and innovation ecosystem in Canada.

Soutien financier dans le développement des connectivités entre les appareils diagnostics et l'application. Support à l'exportation et à la commercialisation Le développement d'un outil d'aide dans la gestion des données dans la lutte à la Résistance antimicrobienne (RAM). Et sa promotion à l'international